{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T14:01:40Z","timestamp":1770040900065,"version":"3.49.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":6525,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1038\/modpathol.3800288","type":"journal-article","created":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T17:28:00Z","timestamp":1096651680000},"page":"421-430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Erythropoietin and erythropoietin receptor expression in human prostate cancer"],"prefix":"10.1016","volume":"18","author":[{"given":"Murat O","family":"Arcasoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin T","family":"Vollmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Demark-Wahnefried","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zishan A","family":"Haroon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.3800288_bib1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood.V77.3.419.419","article-title":"Erythropoietin","volume":"77","author":"Krantz","year":"1991","journal-title":"Blood"},{"key":"10.1038\/modpathol.3800288_bib2","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1182\/blood.V94.6.1864","article-title":"Regulation of the erythropoietin gene","volume":"94","author":"Ebert","year":"1999","journal-title":"Blood"},{"key":"10.1038\/modpathol.3800288_bib3","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1182\/blood-2003-02-0427","article-title":"Guidelines for the use of epoetin in cancer patients: a much-needed step forward in standardizing anemia treatment","volume":"102","author":"Henry","year":"2003","journal-title":"Blood"},{"key":"10.1038\/modpathol.3800288_bib4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0092-8674(89)90965-3","article-title":"Expression cloning of the murine erythropoietin receptor","volume":"57","author":"D'Andrea","year":"1989","journal-title":"Cell"},{"key":"10.1038\/modpathol.3800288_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/blood.V76.1.31.31","article-title":"Human erythropoietin receptor: cloning, expression, and biologic characterization","volume":"76","author":"Jones","year":"1990","journal-title":"Blood"},{"key":"10.1038\/modpathol.3800288_bib6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1182\/blood.V76.1.24.24","article-title":"The gene for the human erythropoietin receptor: analysis of the coding sequence and assignment to chromosome 19p","volume":"76","author":"Winkelmann","year":"1990","journal-title":"Blood"},{"key":"10.1038\/modpathol.3800288_bib7","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1126\/science.283.5404.987","article-title":"Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation","volume":"283","author":"Livnah","year":"1999","journal-title":"Science"},{"key":"10.1038\/modpathol.3800288_bib8","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1126\/science.283.5404.990","article-title":"Erythropoietin receptor activation by a ligand-induced conformation change","volume":"283","author":"Remy","year":"1999","journal-title":"Science"},{"key":"10.1038\/modpathol.3800288_bib9","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.1073\/pnas.87.15.5978","article-title":"Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells","volume":"87","author":"Anagnostou","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.3800288_bib10","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1073\/pnas.91.9.3974","article-title":"Erythropoietin receptor mRNA expression in human endothelial cells","volume":"91","author":"Anagnostou","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.3800288_bib11","doi-asserted-by":"crossref","first-page":"11208","DOI":"10.1016\/S0021-9258(18)82112-3","article-title":"Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells","volume":"268","author":"Masuda","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1038\/modpathol.3800288_bib12","doi-asserted-by":"crossref","first-page":"19488","DOI":"10.1016\/S0021-9258(17)32195-6","article-title":"A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes","volume":"269","author":"Masuda","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1038\/modpathol.3800288_bib13","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1073\/pnas.92.9.3717","article-title":"Localization of specific erythropoietin binding sites in defined areas of the mouse brain","volume":"92","author":"Digicaylioglu","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.3800288_bib14","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1073\/pnas.95.8.4635","article-title":"In vivo evidence that erythropoietin protects neurons from ischemic damage","volume":"95","author":"Sakanaka","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.3800288_bib15","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/35088074","article-title":"Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades","volume":"412","author":"Digicaylioglu","year":"2001","journal-title":"Nature"},{"key":"10.1038\/modpathol.3800288_bib16","doi-asserted-by":"crossref","first-page":"25381","DOI":"10.1074\/jbc.273.39.25381","article-title":"Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis","volume":"273","author":"Yasuda","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1038\/modpathol.3800288_bib17","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0002-9440(10)63459-1","article-title":"A novel role for erythropoietin during fibrin-induced wound-healing response","volume":"163","author":"Haroon","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.3800288_bib18","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/cncr.10787","article-title":"Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma","volume":"95","author":"Acs","year":"2002","journal-title":"Cancer"},{"key":"10.1038\/modpathol.3800288_bib19","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/01.LAB.0000020415.72863.40","article-title":"Functional significance of erythropoietin receptor expression in breast cancer","volume":"82","author":"Arcasoy","year":"2002","journal-title":"Lab Invest"},{"key":"10.1038\/modpathol.3800288_bib20","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0006-291X(03)01303-2","article-title":"Expression of erythropoietin receptor splice variants in human cancer","volume":"307","author":"Arcasoy","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/modpathol.3800288_bib21","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1095\/biolreprod60.4.861","article-title":"Expression of the erythropoietin receptor by trophoblast cellsin the human placenta","volume":"60","author":"Fairchild Benyo","year":"1999","journal-title":"Biol Reprod"},{"key":"10.1038\/modpathol.3800288_bib22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0378-3782(98)00030-9","article-title":"Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus","volume":"52","author":"Juul","year":"1998","journal-title":"Early Hum Dev"},{"key":"10.1038\/modpathol.3800288_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0090-4295(01)01014-7","article-title":"Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features","volume":"58","author":"Demark-Wahnefried","year":"2001","journal-title":"Urology"},{"key":"10.1038\/modpathol.3800288_bib24","first-page":"3561","article-title":"Erythropoietin and erythropoietin receptor expression in human cancer","volume":"61","author":"Acs","year":"2001","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.3800288_bib25","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0002-9440(10)64314-3","article-title":"Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression","volume":"162","author":"Acs","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.3800288_bib26","unstructured":"American Cancer Society. Cancer Facts Figures 2004;16."},{"key":"10.1038\/modpathol.3800288_bib27","first-page":"2861","article-title":"Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers","volume":"54","author":"Gaddipati","year":"1994","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.3800288_bib28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ng0495-401","article-title":"In vivo amplification of the androgen receptor gene and progression of human prostate cancer","volume":"9","author":"Visakorpi","year":"1995","journal-title":"Nat Genet"},{"key":"10.1038\/modpathol.3800288_bib29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/pros.2990220307","article-title":"Insulin-like growth factor I: action and receptor characterization in human prostate cancer cell lines","volume":"22","author":"Iwamura","year":"1993","journal-title":"Prostate"},{"key":"10.1038\/modpathol.3800288_bib30","first-page":"5474","article-title":"Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor","volume":"54","author":"Culig","year":"1994","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.3800288_bib31","first-page":"2942","article-title":"Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease","volume":"62","author":"Hellawell","year":"2002","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.3800288_bib32","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/sj.bjc.6601536","article-title":"Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence","volume":"90","author":"Hernes","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.3800288_bib33","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1182\/blood-2002-06-1767","article-title":"Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology","volume":"100","author":"Rizzo","year":"2002","journal-title":"Blood"},{"key":"10.1038\/modpathol.3800288_bib34","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1200\/JCO.1997.15.3.1218","article-title":"Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group","volume":"15","author":"Glaspy","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.3800288_bib35","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.1998.16.10.3412","article-title":"Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group","volume":"16","author":"Demetri","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.3800288_bib36","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1200\/JCO.2001.19.11.2875","article-title":"Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing","volume":"19","author":"Gabrilove","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.3800288_bib37","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1200\/JCO.2001.19.21.4126","article-title":"Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy","volume":"19","author":"Quirt","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.3800288_bib38","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1200\/JCO.2001.19.11.2865","article-title":"Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial","volume":"19","author":"Littlewood","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.3800288_bib39","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P","article-title":"Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review","volume":"91","author":"Caro","year":"2001","journal-title":"Cancer"},{"key":"10.1038\/modpathol.3800288_bib40","first-page":"1049","article-title":"Importance of serum hemoglobin in hormone refractory prostate cancer","volume":"8","author":"Vollmer","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.3800288_bib41","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/(SICI)1097-0045(199610)29:4<243::AID-PROS5>3.0.CO;2-C","article-title":"Development of anemia and recovery in prostate cancer patients treated with combined androgen blockade and radiotherapy","volume":"29","author":"Asbell","year":"1996","journal-title":"Prostate"},{"key":"10.1038\/modpathol.3800288_bib42","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1046\/j.1464-410X.1997.00234.x","article-title":"Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade","volume":"79","author":"Strum","year":"1997","journal-title":"Br J Urol"},{"key":"10.1038\/modpathol.3800288_bib43","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1080\/003655901750425864","article-title":"Efficacy of epoetin beta on hemoglobin, quality of life, and transfusion needs in patients with anemia due to hormone-refractory prostate cancer\u2014a randomized study","volume":"35","author":"Johansson","year":"2001","journal-title":"Scand J Urol Nephrol"},{"key":"10.1038\/modpathol.3800288_bib44","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1038\/bjc.1998.331","article-title":"Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: final report of a randomized, open-labelled, phase II trial","volume":"77","author":"Sweeney","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.3800288_bib45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/(SICI)1097-0045(19970515)31:3<153::AID-PROS2>3.0.CO;2-M","article-title":"Anemia associated with advanced prostatic adenocarcinoma: effects of recombinant human erythropoietin","volume":"31","author":"Beshara","year":"1997","journal-title":"Prostate"},{"key":"10.1038\/modpathol.3800288_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000052404","article-title":"Erythropoietin in urologic oncology","volume":"39","author":"Albers","year":"2001","journal-title":"Eur Urol"},{"key":"10.1038\/modpathol.3800288_bib47","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1073\/pnas.87.18.6934","article-title":"Structural design and molecular evolution of a cytokine receptor superfamily","volume":"87","author":"Bazan","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.3800288_bib48","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/0955-0674(90)90106-O","article-title":"A new hematopoietic growth factor receptor superfamily: structural features and implications for signal transduction","volume":"2","author":"D'Andrea","year":"1990","journal-title":"Curr Opin Cell Biol"},{"key":"10.1038\/modpathol.3800288_bib49","first-page":"7786","article-title":"Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells","volume":"50","author":"Siegall","year":"1990","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.3800288_bib50","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0022-5347(17)35267-9","article-title":"Interleukin 6 receptor mRNA in prostate carcinomas and benign prostate hyperplasia","volume":"151","author":"Siegsmund","year":"1994","journal-title":"J Urol"},{"key":"10.1038\/modpathol.3800288_bib51","first-page":"141","article-title":"Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro","volume":"57","author":"Okamoto","year":"1997","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.3800288_bib52","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ijc.2910590216","article-title":"Production and response of human prostate cancer cell lines to granulocyte macrophage-colony stimulating factor","volume":"59","author":"Lang","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.3800288_bib53","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood.V91.3.1037","article-title":"Expression of granulocyte\u2013macrophage colony-stimulating factor receptors in human prostate cancer","volume":"91","author":"Rivas","year":"1998","journal-title":"Blood"},{"key":"10.1038\/modpathol.3800288_bib54","first-page":"4640","article-title":"Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor","volume":"58","author":"Hobisch","year":"1998","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.3800288_bib55","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00008390-200010000-00003","article-title":"Erythropoietin receptor expression in human melanoma cells","volume":"10","author":"Selzer","year":"2000","journal-title":"Melanoma Res"},{"key":"10.1038\/modpathol.3800288_bib56","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1046\/j.1523-1755.2000.00211.x","article-title":"Erythropoietin stimulates proliferation of human renal carcinoma cells","volume":"58","author":"Westenfelder","year":"2000","journal-title":"Kidney Int"},{"key":"10.1038\/modpathol.3800288_bib57","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/030089160208800214","article-title":"Erythropoietin and G-CSF receptors in human tumor cells: expression and aspects regarding functionality","volume":"88","author":"Westphal","year":"2002","journal-title":"Tumori"},{"key":"10.1038\/modpathol.3800288_bib58","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1054\/bjoc.2000.1666","article-title":"Inhibition of erythropoietin signalling destroys xenografts of ovarian and uterine cancers in nude mice","volume":"84","author":"Yasuda","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.3800288_bib59","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/carcin\/23.11.1797","article-title":"Erythropoietin is involved in growth and angiogenesis in malignant tumours of female reproductive organs","volume":"23","author":"Yasuda","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1038\/modpathol.3800288_bib60","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1365-2559.2003.01581.x","article-title":"Erythropoietin as an angiogenic factor in gastric carcinoma","volume":"42","author":"Ribatti","year":"2003","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.3800288_bib61","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/carcin\/bgg060","article-title":"Erythropoietin regulates tumour growth of human malignancies","volume":"24","author":"Yasuda","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1038\/modpathol.3800288_bib62","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/01.LAB.0000090156.94795.48","article-title":"Pediatric tumor cells express erythropoietin and a functional erythropoietin receptor that promotes angiogenesis and tumor cell survival","volume":"83","author":"Batra","year":"2003","journal-title":"Lab Invest"},{"issue":"Suppl 1","key":"10.1038\/modpathol.3800288_bib63","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000204780","article-title":"Recombinant human erythropoietin in the treatment of the anaemia of cancer","volume":"87","author":"Abels","year":"1992","journal-title":"Acta Haematol"},{"key":"10.1038\/modpathol.3800288_bib64","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/sj.bjc.6600657","article-title":"Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy","volume":"87","author":"Fallowfield","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.3800288_bib65","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(03)01163-X","article-title":"Breast cancer trial with erythropoietin terminated unexpectedly","volume":"4","author":"Leyland-Jones","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.1038\/modpathol.3800288_bib66","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(03)14567-9","article-title":"Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial","volume":"362","author":"Henke","year":"2003","journal-title":"Lancet"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/3800288.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3800288","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222041710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222041710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3800288.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:17:30Z","timestamp":1760231850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222041710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0893395222041710"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.3800288","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erythropoietin and erythropoietin receptor expression in human prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.3800288","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2005 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}